NATIONS FINANCIAL GROUP INC, /IA/ /ADV
Position in PGEN — Precigen, Inc.
CIK 1109767
CEDAR RAPIDS, IA
Position in PGEN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$94,186
+$34,201 QoQ
Shares Held
16,524
+6.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#155
of 210 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $4,144,884 across 10 Biotechnology names. PGEN ranks #4 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,445 | $2,207,964 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
15,442 | $1,208,645 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
11,272 | $207,066 | |
| 4 | PGEN |
Precigen, Inc.
This page
|
16,524 | $94,186 | |
| 5 | SGMT |
Sagimet Biosciences Inc.
|
12,000 | $92,760 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
14,000 | $85,680 | |
| 7 | IMRX |
Immuneering Corp
|
17,000 | $84,830 | |
| 8 | MNKD |
Mannkind Corp
|
15,451 | $65,821 |
All Filings in PGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,186 | 16,524 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $59,985 | 15,500 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||